Research
Major Milestone Reached in PSC Cancer Risk Study
100 samples collected: DNA methylation study advances early cancer detection in PSC.
Read MoreJanuary 2026 Research Roundup
PSC Support recently attended the British Association for the Study of the Liver (BASL) Immune Special Interest Group (SIG) meeting. This meeting highlighted important progress in research and care, and on new medications for autoimmune liver diseases.
Read MoreProgress Update: Characterising Genetic Changes in Bile Ducts
PSC research on genetic changes in bile ducts is now in its key analytical phase to unlock understanding.
Read MoreMolecular Signatures Identified to Predict Primary Sclerosing Cholangitis Progression and Cancer Risk
New blood-based markers could help predict primary sclerosing cholangitis progression and cancer risk.
Read MorePromising Leap Forward in Research on PSC and Bile Duct Cancer
New research identifies a marker (COX2) linking lab models to real-world PSC patients, advancing early cancer detection efforts.
Read MoreMajor Progress in Developing Simple Blood Test for Earlier Bile Duct Cancer Detection in PSC
Major Progress in Developing Simple Blood Test for Earlier Bile Duct Cancer Detection in PSC
Read MoreResearch Update: New Clues to PSC Progression
Dr Anthony George shares new insights into immune cells and predicting PSC progression.
Read MoreNew PSC Support Research Uncovers Critical Link Between Liver and Small Intestine
PSC Support funding helps uncover new clues in the small intestine for potential new treatments for primary sclerosing cholangitis.
Read MorePSC Treatment Breakthroughs 2025
Discover the 2025 breakthroughs in PSC research and how they are shaping 2026.
Read MoreNov 2025 Research Roundup
Our November roundup features encouraging Phase II trial updates, new gut-liver research, and UK policy changes to speed up rare disease treatment access.
Read More